Log in to save to my catalogue

Availability of and Access to Orphan Drugs: An International Comparison of Pharmaceutical Treatments...

Availability of and Access to Orphan Drugs: An International Comparison of Pharmaceutical Treatments...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_816822588

Availability of and Access to Orphan Drugs: An International Comparison of Pharmaceutical Treatments for Pulmonary Arterial Hypertension, Fabry Disease, Hereditary Angioedema and Chronic Myeloid Leukaemia

About this item

Full title

Availability of and Access to Orphan Drugs: An International Comparison of Pharmaceutical Treatments for Pulmonary Arterial Hypertension, Fabry Disease, Hereditary Angioedema and Chronic Myeloid Leukaemia

Publisher

Cham: Springer International Publishing

Journal title

PharmacoEconomics, 2011-01, Vol.29 (1), p.63-82

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Background
: Market authorization does not guarantee patient access to any given drug. This is particularly true for costly orphan drugs because access depends primarily on co-payments, reimbursement policies and prices. The objective of this article is to identify differences in the availability of orphan drugs and in patient access to them in...

Alternative Titles

Full title

Availability of and Access to Orphan Drugs: An International Comparison of Pharmaceutical Treatments for Pulmonary Arterial Hypertension, Fabry Disease, Hereditary Angioedema and Chronic Myeloid Leukaemia

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_816822588

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_816822588

Other Identifiers

ISSN

1170-7690

E-ISSN

1179-2027

DOI

10.2165/11539190-000000000-00000